Contact
Paul England

Paul England, DPhil

Senior professional support lawyer

Read More
Contact
Paul England

Paul England, DPhil

Senior professional support lawyer

Read More

6 August 2020

Paul England writes on COVID-19 drug supply and patent system for Manufacturing Chemist

The patent system has come under pressure both politically and, more recently, as pharma companies scale-up their operations to make large amounts of drugs available to treat COVID-19.

Paul England outlines what leverage governments have in international negotiations for supplies, particularly when drugs are covered by patents that give them or their chosen licensees the exclusive right to manufacture.

Read the full article on Manufacturing Chemist's website

Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

Scientist studying molecule model
Life sciences & healthcare

Paul England and Simon Cohen launch new life sciences IP guide

23 March 2021

by Paul England, DPhil and Simon Cohen

Click here to find out more